Newsroom
Market News
Both sides of the trade, grades and news round-ups. Click a headline to read it — the arrows walk the list.
Research
- Gogo in Focus: The Bears Have More to Work With
- 1st Source in the Numbers: The Bulls Have More to Work With
- What the Data Says For and Against Uniti Group Inc. (UNIT)
- Recon Technology Leaves Both Camps With Plenty to Point to
- Farmers & Merchants Bancorp: More Bulls Than Bears in the Dossier
- PRA Group in the Numbers: The Bulls Have More to Work With
- TriMas Sets Up a 3-Point Bull Case Against a 5-Point Bear Case
- Pan American Silver: More Bulls Than Bears in the Dossier
- The Bull and Bear Case for Neogen Corporation (NEOG): 8 Points Against 4
- Surgery Partners: One Side Has 7 Points, the Other 5
- The Bull and Bear Case for RADCOM Ltd. (RDCM): 3 Points Against 8
- First Interstate BancSystem Has a Clearer Bull Side, but a Bear Side Too
- What the Data Says For and Against Alpha and Omega Semiconductor (AOSL)
- Inspired Entertainment After the Filings: The Bears Have More to Work With
- United Bankshares: A Mixed Record, With Bulls Holding More Cards
- Gibraltar Industries With The Bulls Have More to Work With and a Bear Case Still Standing
- Orrstown Financial Services Sees the Argument Tilt Toward Bullish
- Horizon Technology Finance: What the Bull-Bear Split Adds Up to
- An Evenly Argued Case for Codexis as the Counts Stack Up
- Home Bancshares in Focus: The Bulls Have More to Work With
- UMB Financial: Beat consensus EPS in 7 of the last 8 quarters as Consensus sees only -32.7% revenue growth in 2026
- U.S. Gold Sets Up a 1-Point Bull Case Against a 3-Point Bear Case
- German American Bancorp: How the Bull and Bear Lists Compare
- ICU Medical Has a Clearer Bull Side, but a Bear Side Too
- Grupo Financiero Galicia: A Mixed Record, With Bulls Holding More Cards
- Omeros: The Bulls Have More to Work With After the Latest Review
- The Bull and Bear Case for Equity Bancshares, Inc. (EQBK): 8 Points Against 3
- Fate Therapeutics: Holds 34.0% above its 200-day average as FY2025 earnings fell 26.8% to -$136.32M
- AtriCure Sets Up an 8-Point Bull Case Against a 2-Point Bear Case
- An Evenly Argued Case for Melco Resorts & Entertainment as the Counts Stack Up
- SSR Mining Looks Bullish by Count, Not by Certainty
- Donegal Has a Clearer Bull Side, but a Bear Side Too
- AeroVironment Stock Soars After Surprising Earnings Beat
- Stock Market Update: Key Trends and Earnings Reports
- Rising Costs Drive AI Companies to Build Data Centers Overseas
- Lockheed Martin, Northrop Grumman, Kinder Morgan, Elanco, Computacenter, and Helus Pharma Set to Speak at Morgan Stanley...
- Meta Makes Major AI Acquisition, Cathie Wood Buys META Stock
- Analysts Bullish on AMD, Macy's, WestGold Metals, Green Bridge Metals, and Toogood Gold Stocks
- Oil Market Update: WTI and Brent Breakout on Supply Fears
- Monolithic vs. Intel: Analyzing Chip Stocks in the Current Market
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with